ZA201501954B - A solid oral pharmaceutical formulation containing ticagrelor - Google Patents
A solid oral pharmaceutical formulation containing ticagrelorInfo
- Publication number
- ZA201501954B ZA201501954B ZA2015/01954A ZA201501954A ZA201501954B ZA 201501954 B ZA201501954 B ZA 201501954B ZA 2015/01954 A ZA2015/01954 A ZA 2015/01954A ZA 201501954 A ZA201501954 A ZA 201501954A ZA 201501954 B ZA201501954 B ZA 201501954B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- solid oral
- oral pharmaceutical
- containing ticagrelor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2012-705A CZ2012705A3 (en) | 2012-10-16 | 2012-10-16 | Solid oral pharmaceutical formulation containing ticagrelor |
| PCT/CZ2013/000130 WO2014059955A1 (en) | 2012-10-16 | 2013-10-15 | A solid oral pharmaceutical formulation containing ticagrelor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201501954B true ZA201501954B (en) | 2017-04-26 |
Family
ID=49619770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2015/01954A ZA201501954B (en) | 2012-10-16 | 2015-03-20 | A solid oral pharmaceutical formulation containing ticagrelor |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2908802A1 (en) |
| JP (1) | JP6301934B2 (en) |
| KR (1) | KR20150067153A (en) |
| CN (1) | CN104661649A (en) |
| BR (1) | BR112015008076A2 (en) |
| CZ (1) | CZ2012705A3 (en) |
| EA (1) | EA201590745A1 (en) |
| HK (1) | HK1205456A1 (en) |
| IL (1) | IL238036B (en) |
| MX (1) | MX2015003866A (en) |
| UA (1) | UA116784C2 (en) |
| WO (1) | WO2014059955A1 (en) |
| ZA (1) | ZA201501954B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160012706A (en) * | 2014-07-25 | 2016-02-03 | 동아에스티 주식회사 | Sustained release formulations |
| CN106074357B (en) * | 2015-04-29 | 2021-07-02 | 江苏恒瑞医药股份有限公司 | Ticagrelor preparation of pharmaceutically acceptable salt thereof |
| CN105193759B (en) * | 2015-09-18 | 2018-07-03 | 乐普药业股份有限公司 | A kind of ticagrelor piece and preparation method thereof |
| CN106667926B (en) * | 2015-11-09 | 2020-01-17 | 石药集团中奇制药技术（石家庄）有限公司 | Favipiravir tablet and preparation method thereof |
| TR201601835A2 (en) * | 2016-02-12 | 2017-08-21 | Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi | PRODUCTION METHOD FOR FORMULATIONS CONTAINING TIKAGRELOR |
| MA44720A (en) * | 2016-04-21 | 2019-02-27 | Astrazeneca Ab | ORAL DISINTEGRATION TABLETS |
| TR201617983A2 (en) * | 2016-12-07 | 2018-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF TICAGRELOR |
| KR102610876B1 (en) * | 2018-03-05 | 2023-12-06 | 주식회사 파마코스텍 | Crystal form I of Ticagrelor Fumarateand its preparing method |
| EP3761965A1 (en) | 2018-03-08 | 2021-01-13 | Pharmaceutical Oriented Services Ltd | Ticagrelor-containing tablet formulation |
| WO2020021110A1 (en) | 2018-07-27 | 2020-01-30 | Krka, D.D., Novo Mesto | Pharmaceutical composition of ticagrelor |
| CN111450067A (en) * | 2019-01-18 | 2020-07-28 | 北京万全德众医药生物技术有限公司 | Ticagrelor dispersible tablet and preparation method thereof |
| CN116370423A (en) * | 2023-02-28 | 2023-07-04 | 天津力生制药股份有限公司 | Ticagrelor orally disintegrating tablet and preparation method thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW530058B (en) | 1997-07-22 | 2003-05-01 | Astra Pharma Prod | Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation |
| JPH11199517A (en) * | 1997-10-31 | 1999-07-27 | Meiji Seika Kaisha Ltd | Intraoral fast disintegrable tablet |
| TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| GB0013407D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Forms of a chemical compound |
| WO2007018057A1 (en) * | 2005-08-05 | 2007-02-15 | Freund Corporation | Tablet rapidly disintegrating in the oral cavity and method of producing the same |
| US20080045548A1 (en) | 2006-08-21 | 2008-02-21 | Astrazeneca Ab | Pharmaceutical Compositions |
| TWI482772B (en) * | 2006-08-21 | 2015-05-01 | Astrazeneca Ab | Compositions, suitable for oral administration, comprising a triazolo(4,5-d)pyrimidin derivate |
| EP2507242A1 (en) | 2009-12-03 | 2012-10-10 | AstraZeneca AB | Co - crystals of a triazolo [4,5 - d]pyrimidine platelet aggregation inhibitor |
| WO2011076749A2 (en) * | 2009-12-23 | 2011-06-30 | Ratiopharm Gmbh | Solid pharmaceutical dosage form |
-
2012
- 2012-10-16 CZ CZ2012-705A patent/CZ2012705A3/en unknown
-
2013
- 2013-10-15 KR KR1020157007818A patent/KR20150067153A/en not_active Application Discontinuation
- 2013-10-15 EP EP13792574.9A patent/EP2908802A1/en not_active Withdrawn
- 2013-10-15 EA EA201590745A patent/EA201590745A1/en unknown
- 2013-10-15 JP JP2015535983A patent/JP6301934B2/en not_active Expired - Fee Related
- 2013-10-15 MX MX2015003866A patent/MX2015003866A/en unknown
- 2013-10-15 WO PCT/CZ2013/000130 patent/WO2014059955A1/en active Application Filing
- 2013-10-15 BR BR112015008076A patent/BR112015008076A2/en not_active IP Right Cessation
- 2013-10-15 UA UAA201504754A patent/UA116784C2/en unknown
- 2013-10-15 CN CN201380050404.5A patent/CN104661649A/en active Pending
-
2015
- 2015-03-20 ZA ZA2015/01954A patent/ZA201501954B/en unknown
- 2015-03-30 IL IL238036A patent/IL238036B/en not_active IP Right Cessation
- 2015-06-24 HK HK15106027.7A patent/HK1205456A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1205456A1 (en) | 2015-12-18 |
| WO2014059955A1 (en) | 2014-04-24 |
| JP2015533129A (en) | 2015-11-19 |
| JP6301934B2 (en) | 2018-03-28 |
| EP2908802A1 (en) | 2015-08-26 |
| CN104661649A (en) | 2015-05-27 |
| IL238036B (en) | 2019-05-30 |
| BR112015008076A2 (en) | 2017-07-04 |
| UA116784C2 (en) | 2018-05-10 |
| KR20150067153A (en) | 2015-06-17 |
| MX2015003866A (en) | 2015-07-17 |
| EA201590745A1 (en) | 2015-08-31 |
| IL238036A0 (en) | 2015-05-31 |
| CZ2012705A3 (en) | 2014-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211209A1 (en) | Pharmaceutical formulation containing thienotriazolodiazepine compounds | |
| HK1205456A1 (en) | A solid oral pharmaceutical formulation containing ticagrelor | |
| EP2906202A4 (en) | Oral drug delivery formulations | |
| HRP20181193T1 (en) | Oral administrable pharmaceutical composition | |
| HK1199821A1 (en) | Oral pharmaceutical composition | |
| GB2486567B (en) | Pharmaceutical formulation | |
| HK1205146A1 (en) | Pharmaceutical formulation | |
| ZA201501897B (en) | A pharmaceutical composition | |
| LT3473255T (en) | Pharmaceutical formulation comprising ciclesonide | |
| HK1207290A1 (en) | Oral formulation | |
| PT2895171T (en) | A stable pharmaceutical formulation containing vardenafil hydrochloride | |
| LT2908836T (en) | Pharmaceutical formulation containing curcuma | |
| HK1204945A1 (en) | Pharmaceutical formulation containing flupirtin | |
| HK1209339A1 (en) | Pharmaceutical formulations | |
| GB201211406D0 (en) | Pharmaceutical formulations | |
| GB201211403D0 (en) | Pharmaceutical formulations | |
| GB201221367D0 (en) | A pharmaceutical composition |